PRESS RELEASE published on 02/01/2024 at 12:30, 2 years 7 months ago Immunic to Participate in Investor and Scientific Conferences in February Immunic, Inc. (Nasdaq: IMUX) to participate in BioCapital Europe 2024 and ACTRIMS Forum 2024 in February and March, presenting clinical pipeline therapies and poster presentations Immunic, Inc. BioCapital Europe 2024 ACTRIMS Forum 2024 Clinical Pipeline Therapies Poster Presentations
PRESS RELEASE published on 11/02/2023 at 11:30, 2 years 10 months ago Immunic Receives Notice of Allowance for United States Patent Protecting the Treatment of Relapsing Multiple Sclerosis with Vidofludimus and Its Salts
PRESS RELEASE published on 10/26/2023 at 12:30, 2 years 10 months ago Immunic to Participate in Scientific and Industry Conferences in November
PRESS RELEASE published on 10/16/2023 at 12:30, 2 years 10 months ago Immunic Presents Data From Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Ulcerative Colitis at the United European Gastroenterology Week 2023
PRESS RELEASE published on 10/15/2023 at 12:30, 2 years 10 months ago Immunic Presents Data From Phase 1b Clinical Trial of IMU-856 in Celiac Disease at the United European Gastroenterology Week 2023
PRESS RELEASE published on 10/11/2023 at 12:30, 2 years 10 months ago Immunic Presents Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis at MSMilan2023: The 9th Joint ECTRIMS-ACTRIMS Meeting
PRESS RELEASE published on 10/09/2023 at 22:01, 2 years 10 months ago Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis
PRESS RELEASE published on 10/04/2023 at 12:30, 2 years 10 months ago Immunic to Participate in Scientific Conferences in October
PRESS RELEASE published on 09/06/2023 at 12:30, 2 years 11 months ago Immunic to Participate in Industry and Investor Conferences in September
PRESS RELEASE published on 08/17/2023 at 12:30, 3 years ago Immunic Completes Enrollment of Its Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis
Published on 09/02/2026 at 22:55, 2 hours 45 minutes ago Secure Blockchain Sells Delivery Trust(R) Business
Published on 09/02/2026 at 18:45, 6 hours 55 minutes ago Full Circle Lithium Rebrands as FCL-X Fire & Safety Inc. and Provides Corporate Update
Published on 09/02/2026 at 15:00, 10 hours 40 minutes ago Vox Royalty Enters into Binding Agreement to Acquire the White Dam Gold Royalty in Australia
Published on 09/02/2026 at 14:30, 11 hours 10 minutes ago Solitario Completes Phase-One Drilling at Golden Crest - Reports Initial Drill Results for Ponderosa
Published on 09/02/2026 at 14:00, 11 hours 40 minutes ago Orogen Royalties Acquires Two Gold Projects in Southwest Utah
Published on 09/03/2026 at 01:05, 34 minutes ago The Royal Mint Boldly Goes Where No Coin Has Gone Before With New Star Trek 50p Coins
Published on 09/02/2026 at 23:55, 1 hour 45 minutes ago Positive Preliminary Feasibility Study (PFS) outlines Vulcan’s second German project showcasing repeatable development growth strategy
Published on 09/02/2026 at 23:45, 1 hour 54 minutes ago EQS-Adhoc: Vulcan Energy Resources Limited: Positive Preliminary Feasibility Study (PFS) outlines Vulcan’s second German project showcasing repeatable development growth strategy
Published on 09/02/2026 at 19:50, 5 hours 49 minutes ago Cotecna Strengthens Food Testing Capabilities in India with Geo-Chem's New Food Safety Laboratory in Navi Mumbai, India
Published on 09/02/2026 at 19:00, 6 hours 40 minutes ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 09/02/2026 at 21:30, 4 hours 10 minutes ago Accor announces the success of OCEANEs due 2032 for a nominal amount of €380 million and the results of the partial repurchase of its outstanding OCEANEs due 2027
Published on 09/02/2026 at 21:30, 4 hours 10 minutes ago Accor annonce le succès d'OCEANEs à échéance 2032 pour un montant nominal de 380 millions d’euros et les résultats du rachat partiel de ses OCEANEs en circulation à échéance 2027
Published on 09/02/2026 at 19:03, 6 hours 36 minutes ago Communiqué au dépôt du projet de note d'information établi par Bourrelier Group
Published on 09/02/2026 at 18:20, 7 hours 20 minutes ago Appointment to Edenred’s Executive Committee
